Microplastics and Cardiovascular Disease: Should Clinicians Be Paying Attention?

Pedro Rafael Vieira de Oliveira Salerno1, Ricardo J Estrada-Mendizabal1, Coral Lozada2

  • 1Department of Medicine, NYC Health & Hospitals/Elmhurst, Icahn School of Medicine at Mount Sinai, New York , Queens, USA.

Current Cardiology Reports
|November 27, 2025
PubMed
Abstract

Insights

Microplastics are found in human cardiovascular tissues and may act as a risk factor. While research is ongoing, current evidence is associative, and personal mitigation is premature.

Area of Science:

  • Environmental Health
  • Cardiology
  • Toxicology

Background:

  • Microplastics (MPs) are increasingly recognized environmental contaminants.
  • Their presence and biological effects are a growing concern in human health.

Purpose of the Study:

  • To introduce clinicians to the potential role of microplastics as a cardiovascular risk factor.
  • To summarize current evidence linking microplastics to cardiovascular health.

Main Methods:

  • Review of in vitro and animal studies on microplastic effects.
  • Analysis of small human studies investigating microplastics in cardiovascular tissues and outcomes.
  • Assessment of evidence limitations including confounding factors and analytical challenges.

Main Results:

  • Microplastics have been detected in human cardiovascular tissues.
  • In vitro and animal studies link MPs to oxidative stress, endothelial dysfunction, and inflammation.
  • Small human studies show associations between MPs and cardiovascular outcomes, but these are associative and method-dependent.

Conclusions:

  • Microplastics are pervasive and biologically plausible cardiovascular risk factors.
  • Current human data is associative, requiring further rigorous investigation.
  • Population-level pollution control is recommended; personal mitigation is premature for clinicians.

Related Concept Videos

Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
363
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
843
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
511
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
332
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
563
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
290